ANI PharmaceuticalsvsMerck & Company

ANIP and MRK stock compared: price, dividend, valuation and results, from SEC filings.

ANIP

ANI Pharmaceuticals, Inc.

$71.47

Value $1.6B

+2.11%
ANIP's page

MRK

Merck & Company, Inc.

$137.78

Value $341B

-3.90%
MRK's page

ANI Pharmaceuticals (ANIP) has a market value of $1.6B and Merck & Company (MRK) $341B. Over the last year, with dividends, ANIP moved -12.8% and MRK +52.7%. The P/E is 13.9 for ANIP and 138.9 for MRK. Dividend yield: ANIP none, MRK 2.47%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ANIP$1.6B

    MRK$341B

    MRK is 212 times ANIP

  • Revenue, 12 months

    ANIP$1.0B

    MRK$67.4B

    MRK is 65 times ANIP

  • Net income, 12 months

    ANIP$117M

    MRK$2.5B

    MRK is 21 times ANIP

  • Operating margin

    ANIP16.0%

    MRK–

  • ROIC

    ANIP14.1%

    MRK3.9%

    10.2 points apart

  • P/E

    ANIP13.9

    MRK138.9

    MRK is 10 times ANIP

  • Dividend yield

    ANIP0.0%

    MRK2.5%

    2.5 points apart

  • 5-year return

    ANIP+63.5%

    MRK+94.3%

    30.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ANIP+63.5%

MRK+94.3%

5010015020020222023202420252026
Returns by period
PeriodANIPWith dividendsMRKWith dividends
1 year since November 17, 2025-12.8%Price -12.8%+52.7%Price +48.4%
3 years since November 17, 2023+39.1%+11.6% a yearPrice +39.1%+48.4%+14.1% a yearPrice +35.4%
5 years since November 17, 2021+63.5%+10.3% a yearPrice +63.5%+94.3%+14.2% a yearPrice +66.8%
10 years since November 18, 2016+23.2%+2.1% a yearPrice +23.2%+216.6%+12.2% a yearPrice +133.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ANIPANI PharmaceuticalsMRKMerck & Company

Valuation

ANIPMRK
Valuation
Price$71.47$137.78
Market value$1.6B$341B
Enterprise value (EV)$1.5B$385B
P/E13.9138.9
P/E, 5-year median–14.8
P/B2.57.6
EV/EBIT8.980.8
Free cash flow yield12.8%4.3%

Results and growth

ANIPMRK
Results and growth
Revenue, 12 months$1.0B$67.4B
Net income, 12 months$117M$2.5B
Free cash flow, 12 months$205M$14.7B
Earnings per share, 12 months$5.01$0.98
Revenue growth, year on year43.8%1.3%
Revenue growth a year, past+33.5%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

ANIPMRK
Margins and returns on capital
Gross margin61.1%71.8%
Operating margin16.0%–
Net margin11.2%3.6%
ROIC14.1%3.9%
ROE20.5%5.2%

Balance sheet

ANIPMRK
Balance sheet
Cash$421M$9.7B
Total debt$298M$53.8B
Net debt / EBITDA-0.55.7
Interest cover5.4×2.4×

Dividends and buybacks

ANIPMRK
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$3.40
Dividend growth a year, past+36.1%over 4 years+5.8%over 5 years
Buyback yield0.8%1.5%
Shareholder yield0.8%4.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ANIP or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, ANI Pharmaceuticals or Merck & Company?

By market value, Merck & Company ($341B) is about 211.9 times ANI Pharmaceuticals ($1.6B), at today's prices.

How did ANIP and MRK stock do over the last 10 years?

Since November 18, 2016, ANIP's price moved +23.2% and MRK's +133.4%. With dividends: ANIP +23.2% (+2.1% a year), MRK +216.6% (+12.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, ANIP or MRK?

The dividend yield at today's price is none for ANI Pharmaceuticals and 2.47% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of ANIP and MRK?

At today's price, the P/E is 13.9 for ANIP and 138.9 for MRK. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, ANI Pharmaceuticals or Merck & Company?

Over the last twelve months, the net margin was 11.2% for ANI Pharmaceuticals and 3.6% for Merck & Company, and the operating margin 16.0% and –. Revenue was $1.0B and $67.4B.

Which is the better investment, ANI Pharmaceuticals or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.